[CBPO] China Biologic Products, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 111.28 Change: 0.93 (0.84%)
Ext. hours: Change: 0 (0%)

chart CBPO

Refresh chart

Strongest Trends Summary For CBPO

CBPO is in the medium-term down -8% in 1 month and up 28% in 6 months and up 27% above S&P in 8 months. In the long-term up 1586% in 16 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: China Biologic Products, Inc., a biopharmaceutical company, is engaged in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers. It offers human albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human albumin and human immunoglobulin for intravenous injection (IVIG) products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides injection for the treatment of original and secondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseas

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS4.79 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y64.77% Sales Growth - 4 Quarters 17.11% Sales Growth - Q/Q21.33% P/E23.04
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA17.23% ROE32.01% ROI
Current Ratio2.51 Quick Ratio1.67 Long Term Debt/Equity Debt Ratio0.52
Gross Margin66.28% Operating Margin45.83% Net Profit Margin29.46% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-2.16 M Cash From Investing Activities-8.47 M Cash From Operating Activities16.54 M Gross Profit45.89 M
Net Profit23.16 M Operating Profit34.75 M Total Assets440 M Total Current Assets308.42 M
Total Current Liabilities122.71 M Total Debt66.3 M Total Liabilities203.14 M Total Revenue70.35 M
Technical Data
High 52 week106.72 Low 52 week60.38 Last close100.76 Last change0.04%
RSI84.37 Average true range1.9 Beta0.44 Volume79.23 K
Simple moving average 20 days3.92% Simple moving average 50 days12.57% Simple moving average 200 days20.41%
Performance Data
Performance Week2.68% Performance Month13.25% Performance Quart25.07% Performance Half57.14%
Performance Year18.54% Performance Year-to-date32.74% Volatility daily0.82% Volatility weekly1.83%
Volatility monthly3.74% Volatility yearly12.96% Relative Volume213.12% Average Volume248.02 K
New High New Low

News

2019-06-13 08:04:13 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-11 08:05:09 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-10 08:04:52 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-06-04 08:02:30 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-05-13 12:23:11 | China Biologic Products Inc CBPO Q1 2019 Earnings Call Transcript

2019-05-10 17:45:09 | China Biologic Products CBPO Tops Q1 Earnings and Revenue Estimates

2019-05-10 16:41:45 | China Biologic Products: 1Q Earnings Snapshot

2019-05-10 16:30:00 | China Biologic Reports Financial Results for the First Quarter of 2019

2019-05-03 10:30:02 | Earnings Preview: China Biologic Products CBPO Q1 Earnings Expected to Decline

2019-04-30 08:00:00 | China Biologic Products to Report First Quarter 2019 Financial Results

2019-04-27 09:07:02 | Is China Biologic Products Inc CBPO A Good Stock To Buy According To Hedge Funds?

2019-04-26 10:30:02 | Analysts Estimate China Biologic Products CBPO to Report a Decline in Earnings: What to Look Out for

2019-04-09 07:26:11 | New Strong Sell Stocks for April 9th

2019-04-04 09:19:01 | New Strong Sell Stocks for April 4th

2019-04-02 11:51:00 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-26 08:21:43 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-22 04:10:08 | New Strong Sell Stocks for March 22nd

2019-03-20 07:23:11 | New Strong Sell Stocks for March 20th

2019-03-19 08:30:15 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-18 10:47:02 | New Strong Sell Stocks for March 18th

2019-03-12 10:28:12 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-03-07 15:21:43 | China Biologic Products Inc CBPO Q4 2018 Earnings Conference Call Transcript

2019-03-06 17:00:00 | China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018

2019-02-25 08:00:00 | China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results

2019-02-04 13:06:31 | Dalton Investments’ Return, AUM, and Holdings

2019-01-31 08:02:41 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-29 08:02:42 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-15 08:01:46 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-09 08:01:47 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2019-01-07 08:00:00 | China Biologic Reiterates Full Year 2018 Financial Forecast

2018-12-22 08:01:40 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-12-17 10:05:00 | David Gao Issues Statement Following Decision by the Grand Court of the Cayman Islands

2018-12-14 08:00:00 | China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman

2018-12-13 06:55:00 | Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and China Biologic Products Holdings

2018-11-24 08:05:17 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-11-20 08:05:20 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-11-01 19:20:33 | China Biologic Products: 3Q Earnings Snapshot

2018-11-01 16:30:00 | China Biologic Reports Financial Results for the Third Quarter of 2018

2018-10-25 08:04:26 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-10-24 08:00:00 | China Biologic Products to Report Third Quarter 2018 Financial Results

2018-10-23 08:04:54 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-10-04 12:48:10 | Investor Criticizes China Biologic Over Rejected Takeover Bid

2018-09-26 07:50:00 | Research Report Identifies The Carlyle Group, China Biologic Products, Ericsson, Dover, GasLog Partners LP, and Spectra Energy Partners, LP with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2018-09-25 08:05:17 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-09-24 09:44:11 | Is China Biologic Products Inc. CBPO A Good Stock To Buy? Centurium Capital Thinks So

2018-09-22 08:03:31 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-08-29 11:59:00 | David Gao Confirms Lawsuit Against China Biologic Products to Protect Shareholders’ Best Interests

2018-08-28 17:00:00 | China Biologic Responds to Lawsuit Filed in Cayman Islands by Former Chairman

2018-08-25 08:03:43 | See what the IHS Markit Score report has to say about China Biologic Products Holdings Inc.

2018-08-24 13:47:50 | China Biologic rejects $3.9 bln bid from former CEO